Comparison Chart Scholar Rock Holding Corporation
Stocks
SRRK
US80706P1030
Biotechnology & Medical Research
|
Market Closed -
Nasdaq
21:00:00 20/08/2026 BST
|
5-day change | 1st Jan Change | ||
| 55.25 USD | -2.23% |
|
+2.66% | +25.43% |
| 08-10 | Scholar Rock Holding Says Apitegromab BLA Review Stays on Track for September 30 PDUFA Date | MT |
| 08-10 | Novo Nordisk works to address FDA's findings at Indiana plant | FW |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| SCHOLAR ROCK HOLDING CORPORATION | Bio Therapeutic Drugs | -2.23% | +2.66% | +25.43% | +83.43% | +46.40% | 6.88B |  | |  |
- Stock Market
- Stocks
- SRRK Stock
- Charts Scholar Rock Holding Corporation
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
